Assistant Professor of Medicine, Dana-Farber Cancer Institute
Hematology
Dr. Gregory A. Abel, MD
|
|
Give Review
Doctor Gregory A. Abel, MD works in the field of Hematology. He went to Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a one of the best medicals schools. Columbia University College of Physicians & Surgeons is ranked 8/52 in Research/PrimaryCare. Gregory Abel is also published. He has 36 publications published. The lastest publication: "Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.' Gregory Abel accepts Medicare.
Publications
- Influence of patient and provider characteristics on quality of care for the Myelodysplastic syndromes.
- Intensity of end-of-life care for patients with Myelodysplastic syndromes: Findings from a large national database.
- Limited stage diffuse large B-cell Lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients.
- Prevalence and impact of financial hardship among New England pediatric stem Cell transplantation families.
- Radiation for diffuse large B-cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project.
- End-of-Life Care for Blood Cancers: A Series of Focus Groups With Hematologic Oncologists.
- Derivation and validation of the SEER-Medicare Myelodysplastic syndromes risk score (SMMRS).
- Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
- Reply to quality control of bone marrow aspirates: Additional steps toward a safer and more efficient procedure.
- Using FastTrack to Implement an Academic Medical Center and Community Health Center Collaborative for Cancer Care Delivery.
- Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia.
- Transformed non-Hodgkin Lymphoma in the rituximab era: analysis of the NCCN outcomes database.
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell Lymphoma treated in the rituximab era.
- Stem cell transplantation for follicular Lymphoma relapsed/refractory after prior rituximab: A comprehensive analysis from the NCCN Lymphoma outcomes project.
- Improving the quality of bone marrow assessment: Impact of operator techniques and use of a specimen preparation checklist.
- Optimal positioning of hematopoietic stem Cell transplantation for older patients with myelodysplastic syndromes.
- Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular Lymphoma and its impact on initial treatment st...
- Low frequency clonal mutations recoverable by deep sequencing in Patients with aplastic Anemia.
- Impact of oncology-related direct-to-consumer advertising: Association with appropriate and inappropriate prescriptions.
- Comparative rates of adverse events with different formulations of intravenous iron.
- Referrals for suspected hematologic malignancy: a survey of primary care physicians.
- Comparative outcome of initial therapy for younger patients with mantle cell Lymphoma: an analysis from the NCCN NHL Database.
- High Rates of Surveillance Imaging for Treated Diffuse Large B-Cell Lymphoma: Findings from a Large National Database.
- Lack of benefit of Central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: Findings from a large national database.
- Sunlight exposure, vitamin D, and risk of non-Hodgkin Lymphoma in the Nurses' Health Study.
- Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic Leukemia.
- The real world: CLL.
- Cancer Disparities in the Context of Medicaid Insurance: A Comparison of Survival for Acute Myeloid Leukemia and Hodgkin's Lymphoma by Medicaid Enrollment.
- Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active Cancer treatment.
- Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network.
- Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations.
- Direct-to-consumer advertising in oncology: a content analysis of print media.
- Direct-to-consumer advertising in oncology.
- Effects of biochemically confirmed smoking cessation on white blood Cell count.
- Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.
Schools
Columbia University College Of Physicians and Surgeons
Massachusetts General Hospital
Dana Farber Cancer Institute
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Breast Cancer
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Columbia University College of Physicians & Surgeons
Hospital
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Dana-Farber Cancer Institute
Drug Facts
| NPI NUMBER | 1285611954 | |
| NPPES Provider LastName | ABEL | |
| NPPES Provider FirstName | GREGORY | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 13.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285611954 |
| Last Name Of The Provider | ABEL |
| First Name Of The Provider | GREGORY |
| View All |
Similar Doctors
|
|
Dr. Walter H. Dzik, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David A. Roth, MD |
|
|
Dr. Kinsey A. McCormick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna F. Farago, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Atish D. Choudhury, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter C. Enzinger, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Stephen E. Sallan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David W. Allen, MD |